← Back to all stories
A Nasal Spray Could Transform TB Treatment, Johns Hopkins Researchers Find
Photo: Diana Polekhina / Unsplash
Researchers at Johns Hopkins Medicine are developing an innovative nasal vaccine that tackles tuberculosis in a completely new way. By combining two TB genes, the vaccine trains the immune system to eliminate drug-resistant bacterial survivors that antibiotics alone can't reach, offering hope for the world's leading infectious disease killer.
Researchers at Johns Hopkins Medicine are developing an innovative nasal vaccine that tackles tuberculosis in a completely new way. By combining two TB genes, the vaccine trains the immune system to eliminate drug-resistant bacterial survivors that antibiotics alone can’t reach, offering hope for the world’s leading infectious disease killer.